Member News
BIOTECanada Welcomes New President & CEO
OTTAWA, ON – On behalf of the Board of Directors of BIOTECanada, Chairman Oliver Technow is pleased to announce the appointment of Wendy Zatylny as the incoming President & CEO… Read More
Member News
Santis Health Expands to Atlantic Canada with the Appointment of Everton McLean as Vice President
TORONTO, ON – Joining Santis Health as Vice President of Atlantic Canada, Everton McLean, a senior communications leader, will drive the firm’s expansion to the East Coast, building on the… Read More
Member News
Labcorp and Inspira Health Announce Strategic Agreement For Lab Operations
Collaboration aims to improve access to innovative diagnostic testing and laboratory services for patients and providers throughout Southern New Jersey BURLINGTON, NC — Labcorp (NYSE: LH), a global leader of… Read More
Member News
Nipocalimab Granted U.S. FDA Priority Review for the Treatment of Generalized Myasthenia Gravis
Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad population of antibody positive adult patients:… Read More
Member News
Johnson & Johnson’s Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer’s Disease
Building on decades of the Company’s Alzheimer’s research, two differentiated investigational therapies aim to slow pathological tau in distinct populations Fast Track designations reinforce J&J’s commitment to Alzheimer’s disease development… Read More